{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:48:15Z","timestamp":1777337295531,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11010-025-05263-6","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:55:48Z","timestamp":1743274548000},"page":"4079-4090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between herpesviruses and alzheimer\u2019s disease: a meta-analysis based on case\u2013control studies"],"prefix":"10.1007","volume":"480","author":[{"given":"Huilin","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfa Ismail","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"5263_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"LJ Soria","year":"2019","unstructured":"Soria LJ, Gonzalez HM, Leger GC (2019) Alzheimer\u2019s disease. Handb Clin Neurol 167:231\u2013255","journal-title":"Handb Clin Neurol"},{"key":"5263_CR2","doi-asserted-by":"crossref","unstructured":"(2021) 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 17(3):327\u2013406","DOI":"10.1002\/alz.12328"},{"issue":"10284","key":"5263_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"9770","key":"5263_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C et al (2011) Alzheimer\u2019s disease. Lancet 377(9770):1019\u20131031","journal-title":"Lancet"},{"issue":"5058","key":"5263_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1126\/science.256.5058.780","volume":"256","author":"KS Kosik","year":"1992","unstructured":"Kosik KS (1992) Alzheimer\u2019s disease: a cell biological perspective. Science 256(5058):780\u2013783","journal-title":"Science"},{"issue":"9","key":"5263_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10(9):698\u2013712","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5263_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"issue":"12","key":"5263_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.tim.2012.08.005","volume":"20","author":"AC Wilson","year":"2012","unstructured":"Wilson AC, Mohr I (2012) A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol 20(12):604\u2013611","journal-title":"Trends Microbiol"},{"issue":"2","key":"5263_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13365-014-0312-0","volume":"21","author":"E Jennische","year":"2015","unstructured":"Jennische E et al (2015) The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection. J Neurovirol 21(2):129\u2013147","journal-title":"J Neurovirol"},{"key":"5263_CR10","first-page":"2711","volume":"18","author":"ND Shukla","year":"2012","unstructured":"Shukla ND, Tiwari V, Valyi-Nagy T (2012) Nectin-1-specific entry of herpes simplex virus 1 is sufficient for infection of the cornea and viral spread to the trigeminal ganglia. Mol Vis 18:2711\u20132716","journal-title":"Mol Vis"},{"key":"5263_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","volume":"66","author":"G Smith","year":"2012","unstructured":"Smith G (2012) Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol 66:153\u2013176","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"5263_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","volume":"13","author":"MJ Bradshaw","year":"2016","unstructured":"Bradshaw MJ, Venkatesan A (2016) Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 13(3):493\u2013508","journal-title":"Neurotherapeutics"},{"key":"5263_CR13","doi-asserted-by":"publisher","first-page":"175909142110535","DOI":"10.1177\/17590914211053505","volume":"14","author":"S Zhang","year":"2022","unstructured":"Zhang S et al (2022) Simultaneous detection of herpes simplex virus type 1 latent and lytic transcripts in brain tissue. ASN Neuro 14:17590914211053504","journal-title":"ASN Neuro"},{"issue":"1","key":"5263_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/alz.12008","volume":"16","author":"M Linard","year":"2020","unstructured":"Linard M et al (2020) Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer\u2019s disease. Alzheimers Dement 16(1):200\u2013208","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5263_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA et al (2018) Alzheimer\u2019s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99(1):56-63.e3","journal-title":"Neuron"},{"issue":"3","key":"5263_CR16","doi-asserted-by":"publisher","first-page":"e1007617","DOI":"10.1371\/journal.ppat.1007617","volume":"15","author":"G De Chiara","year":"2019","unstructured":"De Chiara G et al (2019) Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog 15(3):e1007617","journal-title":"PLoS Pathog"},{"key":"5263_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/v11100966","author":"CA Mangold","year":"2019","unstructured":"Mangold CA, Szpara ML (2019) Persistent infection with herpes simplex virus 1 and alzheimer\u2019s disease-a call to study how variability in both virus and host may impact disease. Viruses. https:\/\/doi.org\/10.3390\/v11100966","journal-title":"Viruses"},{"issue":"6","key":"5263_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00018-023-04817-5","volume":"80","author":"PD Li","year":"2023","unstructured":"Li PD et al (2023) Interleukin 1beta triggers synaptic and memory deficits in Herpes simplex virus type-1-infected mice by downregulating the expression of synaptic plasticity-related genes via the epigenetic MeCP2\/HDAC4 complex. Cell Mol Life Sci 80(6):172","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"5263_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00702-017-1745-4","volume":"125","author":"JM Taylor","year":"2018","unstructured":"Taylor JM et al (2018) Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer\u2019s disease. J Neural Transm (Vienna) 125(5):797\u2013807","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"5263_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141(1):39\u201365","journal-title":"Acta Neuropathol"},{"issue":"7","key":"5263_CR21","doi-asserted-by":"publisher","first-page":"e1002124","DOI":"10.1371\/journal.ppat.1002124","volume":"7","author":"L Vastag","year":"2011","unstructured":"Vastag L et al (2011) Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 7(7):e1002124","journal-title":"PLoS Pathog"},{"key":"5263_CR22","doi-asserted-by":"publisher","first-page":"6547248","DOI":"10.1155\/2016\/6547248","volume":"2016","author":"D Limongi","year":"2016","unstructured":"Limongi D, Baldelli S (2016) Redox imbalance and viral infections in neurodegenerative diseases. Oxid Med Cell Longev 2016:6547248","journal-title":"Oxid Med Cell Longev"},{"issue":"Suppl","key":"5263_CR23","first-page":"1","volume":"36","author":"AR Nafchi","year":"2022","unstructured":"Nafchi AR et al (2022) Autophagy and herpesvirus: a collaboration contributing to alzheimer\u2019s disease. FASEB J 36(Suppl):1","journal-title":"FASEB J"},{"issue":"3","key":"5263_CR24","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M et al (2019) Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol 29(3):e2034","journal-title":"Rev Med Virol"},{"key":"5263_CR25","doi-asserted-by":"publisher","first-page":"105777","DOI":"10.1016\/j.earlhumdev.2023.105777","volume":"182","author":"A Keymeulen","year":"2023","unstructured":"Keymeulen A et al (2023) Neurodevelopmental outcome in children with congenital cytomegalovirus infection: a prospective multicenter cohort study. Early Hum Dev 182:105777","journal-title":"Early Hum Dev"},{"key":"5263_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pnpbp.2013.09.003","volume":"48","author":"J Houenou","year":"2014","unstructured":"Houenou J et al (2014) Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 48:142\u2013148","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"5263_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/infdis\/jit210","volume":"208","author":"NS Lurain","year":"2013","unstructured":"Lurain NS et al (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 208(4):564\u2013572","journal-title":"J Infect Dis"},{"issue":"1","key":"5263_CR28","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1038\/s41598-021-87963-9","volume":"11","author":"MJ Murphy","year":"2021","unstructured":"Murphy MJ et al (2021) Herpes simplex virus 1 and the risk of dementia: a population-based study. Sci Rep 11(1):8691","journal-title":"Sci Rep"},{"issue":"2","key":"5263_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/infdis\/jiu437","volume":"211","author":"LL Barnes","year":"2015","unstructured":"Barnes LL et al (2015) Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis 211(2):230\u2013237","journal-title":"J Infect Dis"},{"key":"5263_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fneur.2017.00040","volume":"8","author":"G Westman","year":"2017","unstructured":"Westman G et al (2017) Decreased HHV-6 IgG in Alzheimer\u2019s disease. Front Neurol 8:40","journal-title":"Front Neurol"},{"key":"5263_CR31","unstructured":"Wells GA et al (2023) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 22 Feb 2023"},{"issue":"3","key":"5263_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-161305","volume":"61","author":"H Lovheim","year":"2018","unstructured":"Lovheim H et al (2018) Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer\u2019s disease development. J Alzheimers Dis 61(3):939\u2013945","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"5263_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4049\/jimmunol.2000351","volume":"205","author":"JP Pandey","year":"2020","unstructured":"Pandey JP et al (2020) An Ig gamma marker genotype is a strong risk factor for Alzheimer disease, independent of apolipoprotein E epsilon4 genotype. J Immunol 205(5):1318\u20131322","journal-title":"J Immunol"},{"key":"5263_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fnagi.2014.00285","volume":"6","author":"R Mancuso","year":"2014","unstructured":"Mancuso R et al (2014) Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer\u2019s disease and amnestic mild cognitive impairment. Front Aging Neurosci 6:285","journal-title":"Front Aging Neurosci"},{"key":"5263_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020255","author":"R Mancuso","year":"2020","unstructured":"Mancuso R et al (2020) HSV-1-Specific IgG(3) titers correlate with brain cortical thinning in individuals with mild cognitive impairment and Alzheimer\u2019s disease. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines8020255","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"5263_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-150464","volume":"49","author":"S Agostini","year":"2016","unstructured":"Agostini S et al (2016) Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis 49(1):229\u2013235","journal-title":"J Alzheimers Dis"},{"issue":"9047","key":"5263_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"RF Itzhaki","year":"1997","unstructured":"Itzhaki RF et al (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet 349(9047):241\u2013244","journal-title":"Lancet"},{"issue":"3","key":"5263_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2990.1990.tb01158.x","volume":"16","author":"AM Deatly","year":"1990","unstructured":"Deatly AM et al (1990) Human herpes virus infections and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 16(3):213\u2013223","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"5263_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jmv.20271","volume":"75","author":"MA Wozniak","year":"2005","unstructured":"Wozniak MA et al (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer\u2019s disease patients. J Med Virol 75(2):300\u2013306","journal-title":"J Med Virol"},{"issue":"5","key":"5263_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jcla.1860040510","volume":"4","author":"A Ounanian","year":"1990","unstructured":"Ounanian A et al (1990) Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer\u2019s disease. J Clin Lab Anal 4(5):367\u2013375","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"5263_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbrc.2012.12.054","volume":"430","author":"N Kobayashi","year":"2013","unstructured":"Kobayashi N et al (2013) Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer\u2019s disease. Biochem Biophys Res Commun 430(3):907\u2013911","journal-title":"Biochem Biophys Res Commun"},{"key":"5263_CR42","doi-asserted-by":"crossref","unstructured":"Beffert U et al (1998) Herpes Simplex Virus Type 1 in the Brain, Apolipoprotein E Genotype and Alzheimer\u2019s Disease. McGill J Med 4(1):4\u20138","DOI":"10.26443\/mjm.v4i1.656"},{"issue":"1\u20132","key":"5263_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/BF00685344","volume":"60","author":"DM Mann","year":"1983","unstructured":"Mann DM, Tinkler AM, Yates PO (1983) Neurological disease and herpes simplex virus. An immunohistochemical study. Acta Neuropathol 60(1\u20132):24\u201328","journal-title":"Acta Neuropathol"},{"issue":"4","key":"5263_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.1711670403","volume":"167","author":"GA Jamieson","year":"1992","unstructured":"Jamieson GA et al (1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 167(4):365\u2013368","journal-title":"J Pathol"},{"issue":"1\u20133","key":"5263_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02815215","volume":"28","author":"WR Lin","year":"1996","unstructured":"Lin WR, Shang D, Itzhaki RF (1996) Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease. Mol Chem Neuropathol 28(1\u20133):135\u2013141","journal-title":"Mol Chem Neuropathol"},{"issue":"9058","key":"5263_CR46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0140-6736(05)62325-2","volume":"349","author":"S Itabashi","year":"1997","unstructured":"Itabashi S et al (1997) Herpes simplex virus and risk of Alzheimer\u2019s disease. Lancet 349(9058):1102","journal-title":"Lancet"},{"issue":"1","key":"5263_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/135502801300069773","volume":"7","author":"AR Marques","year":"2001","unstructured":"Marques AR et al (2001) Lack of association between HSV-1 DNA in the brain, Alzheimer\u2019s disease and apolipoprotein E4. J Neurovirol 7(1):82\u201383","journal-title":"J Neurovirol"},{"issue":"2","key":"5263_CR48","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/JCM.42.2.936-937.2004","volume":"42","author":"I Mori","year":"2004","unstructured":"Mori I et al (2004) PCR search for the herpes simplex virus type 1 genome in brain sections of patients with familial Alzheimer\u2019s disease. J Clin Microbiol 42(2):936\u2013937","journal-title":"J Clin Microbiol"},{"issue":"12","key":"5263_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/ene.12477","volume":"22","author":"XL Bu","year":"2015","unstructured":"Bu XL et al (2015) A study on the association between infectious burden and Alzheimer\u2019s disease. Eur J Neurol 22(12):1519\u20131525","journal-title":"Eur J Neurol"},{"issue":"2","key":"5263_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ana.10662","volume":"54","author":"N Hemling","year":"2003","unstructured":"Hemling N et al (2003) Herpesviruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann Neurol 54(2):267\u2013271","journal-title":"Ann Neurol"},{"issue":"1","key":"5263_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/ADR-210008","volume":"5","author":"LK Lopatko","year":"2021","unstructured":"Lopatko LK et al (2021) Plasma amyloid-beta in relation to antibodies against herpes simplex virus, cytomegalovirus, and chlamydophila pneumoniae. J Alzheimers Dis Rep 5(1):229\u2013235","journal-title":"J Alzheimers Dis Rep"},{"issue":"5","key":"5263_CR52","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/alz.12834","volume":"19","author":"O Goldhardt","year":"2023","unstructured":"Goldhardt O et al (2023) Herpes simplex virus alters Alzheimer\u2019s disease biomarkers - a hypothesis paper. Alzheimers Dement 19(5):2117\u20132134","journal-title":"Alzheimers Dement"},{"key":"5263_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1290","author":"P Luke Liu","year":"2022","unstructured":"Luke Liu P et al (2022) Association between herpes simplex virus type 1 and the risk of alzheimer\u2019s disease. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofac492.1290","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"5263_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-130977","volume":"38","author":"R Mancuso","year":"2014","unstructured":"Mancuso R et al (2014) Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer\u2019s disease. J Alzheimers Dis 38(4):741\u2013745","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"5263_CR55","doi-asserted-by":"publisher","first-page":"e77921","DOI":"10.1371\/journal.pone.0077921","volume":"8","author":"G Westman","year":"2013","unstructured":"Westman G et al (2013) Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of general immunosenescence in Alzheimer\u2019s disease. PLoS ONE 8(10):e77921","journal-title":"PLoS ONE"},{"key":"5263_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115738","author":"R Bello-Morales","year":"2021","unstructured":"Bello-Morales R et al (2021) HSV-1 and endogenous retroviruses as risk factors in demyelination. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115738","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5263_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41398-023-02376-8","volume":"13","author":"MA Albaret","year":"2023","unstructured":"Albaret MA et al (2023) HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer\u2019s disease. Transl Psychiatry 13(1):86","journal-title":"Transl Psychiatry"},{"issue":"2","key":"5263_CR58","doi-asserted-by":"publisher","first-page":"430.e19","DOI":"10.1016\/j.neurobiolaging.2010.12.010","volume":"33","author":"S Santana","year":"2012","unstructured":"Santana S et al (2012) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging 33(2):430.e19-430.e33","journal-title":"Neurobiol Aging"},{"issue":"3","key":"5263_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3233\/JAD-2010-101386","volume":"23","author":"R Lerchundi","year":"2011","unstructured":"Lerchundi R et al (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. J Alzheimers Dis 23(3):513\u2013520","journal-title":"J Alzheimers Dis"},{"key":"5263_CR60","doi-asserted-by":"publisher","first-page":"113157","DOI":"10.1016\/j.psychres.2020.113157","volume":"291","author":"F Dickerson","year":"2020","unstructured":"Dickerson F et al (2020) The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: a meta-analysis. Psychiatry Res 291:113157","journal-title":"Psychiatry Res"},{"issue":"2","key":"5263_CR61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JAD-140822","volume":"47","author":"AJ Steel","year":"2015","unstructured":"Steel AJ, Eslick GD (2015) Herpes viruses increase the risk of Alzheimer\u2019s disease: a meta-analysis. J Alzheimers Dis 47(2):351\u2013364","journal-title":"J Alzheimers Dis"},{"issue":"Pt A","key":"5263_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2020.10.044","volume":"82","author":"D Wu","year":"2020","unstructured":"Wu D et al (2020) The association between herpes simplex virus type 1 infection and Alzheimer\u2019s disease. J Clin Neurosci 82(Pt A):63\u201370","journal-title":"J Clin Neurosci"},{"issue":"1","key":"5263_CR63","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1038\/s41598-019-41218-w","volume":"9","author":"C Warren-Gash","year":"2019","unstructured":"Warren-Gash C et al (2019) Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep 9(1):4743","journal-title":"Sci Rep"},{"issue":"3","key":"5263_CR64","doi-asserted-by":"publisher","first-page":"e1008335","DOI":"10.1371\/journal.ppat.1008335","volume":"16","author":"W Wang","year":"2020","unstructured":"Wang W et al (2020) STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog 16(3):e1008335","journal-title":"PLoS Pathog"},{"issue":"2","key":"5263_CR65","doi-asserted-by":"publisher","first-page":"e0229570","DOI":"10.1371\/journal.pone.0229570","volume":"15","author":"AH Karaba","year":"2020","unstructured":"Karaba AH et al (2020) Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1. PLoS ONE 15(2):e0229570","journal-title":"PLoS ONE"},{"issue":"5","key":"5263_CR66","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2004.01.007","volume":"25","author":"RG Nagele","year":"2004","unstructured":"Nagele RG et al (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer\u2019s disease. Neurobiol Aging 25(5):663\u2013674","journal-title":"Neurobiol Aging"},{"key":"5263_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC (2019) Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: rational insights for the therapeutic approaches. J Clin Neurosci 59:6\u201311","journal-title":"J Clin Neurosci"},{"issue":"3","key":"5263_CR68","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M et al (2021) NLRP3 inflammasome: a starring role in amyloid-beta- and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimers Dis 83(3):939\u2013961","journal-title":"J Alzheimers Dis"},{"key":"5263_CR69","doi-asserted-by":"publisher","first-page":"570711","DOI":"10.3389\/fneur.2020.570711","volume":"11","author":"KL Hanslik","year":"2020","unstructured":"Hanslik KL, Ulland TK (2020) The role of microglia and the Nlrp3 inflammasome in Alzheimer\u2019s disease. Front Neurol 11:570711","journal-title":"Front Neurol"},{"key":"5263_CR70","doi-asserted-by":"publisher","first-page":"838808","DOI":"10.3389\/fmicb.2022.838808","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X et al (2022) Herpes simplex virus 1 induces microglia gasdermin D-dependent pyroptosis through activating the NLR family pyrin domain containing 3 inflammasome. Front Microbiol 13:838808","journal-title":"Front Microbiol"},{"issue":"9","key":"5263_CR71","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/glia.22689","volume":"62","author":"AJ Chucair-Elliott","year":"2014","unstructured":"Chucair-Elliott AJ et al (2014) Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia 62(9):1418\u20131434","journal-title":"Glia"},{"issue":"1","key":"5263_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamaneurol.2021.4417","volume":"79","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R et al (2022) Research criteria for the behavioral variant of alzheimer disease: a systematic review and meta-analysis. JAMA Neurol 79(1):48\u201360","journal-title":"JAMA Neurol"},{"issue":"2","key":"5263_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamaneurol.2020.4152","volume":"78","author":"VL Feigin","year":"2021","unstructured":"Feigin VL et al (2021) Burden of neurological disorders across the US from 1990\u20132017: a global burden of disease study. JAMA Neurol 78(2):165\u2013176","journal-title":"JAMA Neurol"},{"issue":"Suppl 1","key":"5263_CR74","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/343739","volume":"186","author":"JS Smith","year":"2002","unstructured":"Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186(Suppl 1):S3\u2013S28","journal-title":"J Infect Dis"},{"issue":"5","key":"5263_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2471\/BLT.19.237149","volume":"98","author":"C James","year":"2020","unstructured":"James C et al (2020) Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ 98(5):315\u2013329","journal-title":"Bull World Health Organ"},{"issue":"5","key":"5263_CR76","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/cid\/ciy562","volume":"68","author":"L Khadr","year":"2019","unstructured":"Khadr L et al (2019) The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions. Clin Infect Dis 68(5):757\u2013772","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5263_CR77","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Viejo-Borbolla A (2021) Pathogenesis and virulence of herpes simplex virus. Virulence 12(1):2670\u20132702","journal-title":"Virulence"},{"issue":"1","key":"5263_CR78","doi-asserted-by":"publisher","first-page":"e12187","DOI":"10.1002\/trc2.12187","volume":"7","author":"ES Hemmingsson","year":"2021","unstructured":"Hemmingsson ES et al (2021) Antiviral treatment associated with reduced risk of clinical Alzheimer\u2019s disease-A nested case-control study. Alzheimers Dement (N Y) 7(1):e12187","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"5263_CR79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1574891X10666150509193236","volume":"10","author":"KG Faldu","year":"2015","unstructured":"Faldu KG, Shah JS, Patel SS (2015) Anti-viral agents in neurodegenerative disorders: new paradigm for targeting alzheimer\u2019s disease. Recent Pat Antiinfect Drug Discov 10(2):76\u201383","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"10","key":"5263_CR80","doi-asserted-by":"publisher","first-page":"e25152","DOI":"10.1371\/journal.pone.0025152","volume":"6","author":"MA Wozniak","year":"2011","unstructured":"Wozniak MA et al (2011) Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS ONE 6(10):e25152","journal-title":"PLoS ONE"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05263-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05263-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05263-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:26:25Z","timestamp":1757157985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05263-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5263"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05263-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants and animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}